NetworkNewsBreaks

WednesdayMar 29, 2017 11:10 am

NetworkNewsBreaks – Players Network, Inc. (PNTV) Presenting at America First Investment Luncheon on March 31, 2017

Players Network’s (OTCQB: PNTV) CEO Mark Bradley and Director Brett H. Pojunis are set to present at the "America First Investment" financial luncheon hosted by ClubsCorp Business Network in Las Vegas on March 31, 2017, from 12:30-3:00 p.m. PDT. The diversified holding company was invited to present at the luncheon series that features select emerging companies who will present to attending investment bankers, institutional investors, and individual accredited investors. In addition to the presentation, both Bradley and Pojunis will be available for one-on-one meetings with investors. To register visit: https://goo.gl/gnkPRJ To view the full press release, visit: http://nnw.fm/Z3TrT About Players…

Continue Reading

TuesdayMar 28, 2017 1:59 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 28, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: VPRB 23.00% – News: Sets date for grand opening of The Vape and Smoke Store on April 20 VTSI 21.67% – News: Secures international contract; sets record number of Q1 orders MBII 11.49% – News: Advancing novel bacteria and related proteins identified by Evogene (NASDAQ: EVGN) into bioinsecticide pipeline IGXT 14.12% – News: Receives exclusive license for Tadalafil ED dosing patent RPMT 10.00% – News: Inks definitive agreement with Be Informed BV STRM 8.33%…

Continue Reading

TuesdayMar 28, 2017 10:58 am

NetworkNewsBreaks – Cempra, Inc. (NASDAQ: CEMP) Pulls Marketing Authorization Application for Solithromycin in Europe

Shares of Cempra (NASDAQ: CEMP) are down 5% mid-morning after the company said that it has withdrawn its marketing authorization application (MAA) seeking European Medicines Agency (EMA) approval of oral capsule and intravenous formulations of solithromycin for the treatment of community-acquired pneumonia in adults. The decision to withdraw was made based off of the Day 120 questions from the EMA, which caused the company to believe that additional data would be required. The company is now able to realign its strategy to provide additional data to both the EMA and U.S. Food and Drug Administration (FDA) to support potential approval.…

Continue Reading

TuesdayMar 28, 2017 10:45 am

NetworkNewsBreaks – Akers Biosciences, Inc. (NASDAQ: AKER) Receives Initial Order for Cholesterol Test from First Check; Shares Surge

Shares of Akers Biosciences (NASDAQ: AKER) climbed 71% on news of the company receiving an initial order for its rapid cholesterol self-test from First Check Diagnostics, LLC, the exclusive distributor for this product in the United States, for sale under its popular "First Check" brand. Akers’ Tri-Cholesterol "Check" test provides an estimate of a person's total cholesterol as well as his or her high density lipoprotein cholesterol levels, or 'good cholesterol'. This provides the user with an estimate of his or her low density lipoprotein levels, or 'bad cholesterol', making it an effective screening test for high cholesterol. "I am…

Continue Reading

TuesdayMar 28, 2017 10:41 am

NetworkNewsBreaks – RXi Pharmaceuticals Corp. (NASDAQ: RXII) Strengthens RXI-109 Intellectual Property with New Patent in Japan; Shares Rise

RXi Pharmaceuticals (NASDAQ: RXII) shares are up more than 38% this morning after the company said it has been granted a patent by the Japan Patent Office for the composition of matter of sd-rxRNAs targeting connective tissue growth factor for the treatment or prevention of fibrotic disorders. Fibrotic disorders covered include, but are not limited to, skin fibrosis and proliferative retinopathy. This patent includes RXI-109, the company’s lead clinical candidate, which is currently being evaluated in phase 2 clinical trials. The patent will expire in 2031. "The granting of this patent in Japan further strengthens RXi's intellectual property estate for…

Continue Reading

MondayMar 27, 2017 11:20 am

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 27, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: OBMP 18.17% – News: Exceeds sales projections for licensed products EMMD 10.43% – News: Acquires new online travel portal ICAD 9.61% – News: Receives pre-market FDA approval for PowerLook® Tomo Detection NXTD 9.46% – News: Enters LOI with Fit Pay, Inc. to combine businesses EKSO 8.55% – News: Presenting at the ProCore Groundbreak 2017 construction technology conference March 29-31 JTPY 6.38% – News: Posts Q4, FY 2016 results TROV 5.52% – News: Presenting at…

Continue Reading

MondayMar 27, 2017 11:20 am

NetworkNewsBreaks – DryShips, Inc. (NASDAQ: DRYS) Acquires Four Modern Newcastlemax Vessels

DryShips (NASDAQ: DRYS) this morning said that it has entered into agreements with unaffiliated third parties to acquire four modern Newcastlemax bulk carriers of approximately 206,000 DWT and with an average age of 3.0 years. Two of the vessels will be employed under time charter contracts, while the other two will trade in the spot market. DryShips will finance the total gross purchase price of approximately $124 million using cash on hand, and it expects to take delivery of the vessels before the end of June 2017. "We are very pleased to have increased the size of our drybulk fleet by…

Continue Reading

MondayMar 27, 2017 11:19 am

NetworkNewsBreaks – Foamix Pharmaceuticals (NASDAQ: FOMX) Shares Sink on Report of Topline Results from Phase 3 Trials for FMX101

Shares of Foamix Pharmaceuticals (NASDAQ: FOMX) dove 50% this morning following the company’s report of topline results from its two phase 3 clinical trials investigating FMX101 (Trial 04 and Trial 05) in patients with moderate-to-severe acne. The two co-primary endpoints were the absolute change in the number of inflammatory lesions (papules and pustules); and the proportion of patients achieving success at week 12, as defined by an Investigator's Global Assessment (IGA) score of "clear" or "almost clear" and at least a two-grade improvement from baseline at week 12. FMX101 did not demonstrate statistical significance of IGA success in Trial 04.…

Continue Reading

MondayMar 27, 2017 9:38 am

NetworkNewsBreaks – eXp World Holdings, Inc. (EXPI) Scheduled to Present at The MicroCap Conference on April 4

eXp World Holdings, Inc. (OTCQB: EXPI), holding company for the Agent-Owned Cloud Brokerage®, this morning announced that its management team will be attending The MicroCap Conference in New York on Tuesday, April 4, 2017. The company is scheduled to present at 9:30 a.m. ET at the JW Marriott Essex House New York, which is located adjacent to Central Park in Manhattan. The EXPI team will also host one-on-one meetings with prospective investors throughout the day. A webcast of the company’s presentation will be made available at http://wsw.com/webcast/microcapconf3/expi for those who are unable to attend the event. For more information about…

Continue Reading

FridayMar 24, 2017 11:55 am

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on March 24, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ZAIS 47.73% – News: Posts Q4, FY 2016 results LKAI 23.07% – News: Three largest shareholders increased their holdings ADAC 16.00% – News: Secures contracts with two marquis clients EBIO 8.42% – News: Posts Q4, FY 2016 results TLRS 7.66% – News: Increases and extends private placement HDYN 6.21% – News: Reconvening annual stockholders meeting on April 19 ENCR 5.94% – News: Holding a conference call to discuss FY 2016 on April 13 FNJN…

Continue Reading